1. Home
  2. AIRS vs MASS Comparison

AIRS vs MASS Comparison

Compare AIRS & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIRS

AirSculpt Technologies Inc.

HOLD

Current Price

$4.42

Market Cap

328.7M

Sector

Health Care

ML Signal

HOLD

Logo 908 Devices Inc.

MASS

908 Devices Inc.

HOLD

Current Price

$8.70

Market Cap

326.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRS
MASS
Founded
2012
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
328.7M
326.0M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
AIRS
MASS
Price
$4.42
$8.70
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
619.1K
295.0K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
125.47
EPS
N/A
N/A
Revenue
$151,818,000.00
$56,197,000.00
Revenue This Year
$5.19
$19.44
Revenue Next Year
$5.32
$18.63
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.51
$5.03
52 Week High
$12.00
$9.34

Technical Indicators

Market Signals
Indicator
AIRS
MASS
Relative Strength Index (RSI) 42.71 55.95
Support Level $2.40 $7.57
Resistance Level $5.79 $9.21
Average True Range (ATR) 0.29 0.44
MACD -0.10 -0.03
Stochastic Oscillator 3.91 49.77

Price Performance

Historical Comparison
AIRS
MASS

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.

About MASS 908 Devices Inc.

908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.

Share on Social Networks: